Evaluating the effect of Phyllanthus Emblica, Rosa Damascene, Marshmallow and Honey on COVID 19
Phase 3
- Conditions
- COVID 19.Corona virus infection, unspecifiedU07.1
- Registration Number
- IRCT20200404046937N3
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age =18 years
Laboratory polymerase chain reaction (PCR) confirmed infection with COVID19
Lung involvement confirmed with chest imaging
Hospitalized with: Fever or Respiratory rate >24/min Or Cough
Less than 8 days since illness onset
Willingness of study participant to accept randomization to any assigned treatment arm
Acceptance of non-participation in another study before the 28th day of the study
Exclusion Criteria
Receipt of any experimental treatment for COVID 19 within the 30 days prior to the time of the screening evaluation
Severe liver disease
Known allergic reaction to drugs
Severe renal disease
Pregnant or breastfeeding women
Transfer to another hospital within the next 72 hours
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Viral diagnostic test. Timepoint: The first day of the study and the end of the study. Method of measurement: Polymerase chain reaction.
- Secondary Outcome Measures
Name Time Method